Fatty Liver Disease

Be part of clinical trials. Do something rewarding.

Start online screening
Therapy areas Diabetes Digestion & Bowel

An estimated 20-30% of the UK population has non-alcoholic fatty liver disease. For those with NASH, no medication is available to reverse the fat build up in the liver and the disease may continue to progress.

  • We are looking for volunteers to take part in clinical trials to better understand the condition and help find new treatments.
  • Appropriate volunteers will receive a free fibroscan, a procedure that helps assess the damage in the liver and not always available on the NHS.
  • Synexus can also help with transport to and from one of our clinics or reimburse reasonable travel expenses.

All Synexus trials are approved by an independent ethics committee.

To enable us to assess your suitability for upcoming clinical trials please:

Click ‘Call Now’ to speak to our team
0800 880 7001

Click to screen now and book an appointment

Call to find out more

0800 880 7001

Are You at Risk for Fatty Liver?

Being at risk for NASH can be linked to a number of health factors. To see if you may be at risk and discover your next step, please enter the information below.

Age

NASH risk increases with age.

BMI

People with a high BMI are at higher risk of developing NASH.

Pre-diabetes or Diabetes?

Having insulin resistance is linked to a higher risk of having NASH.

Blood Pressure

People with elevated blood pressure may be at risk of developing NASH.

Cholesterol

People with elevated cholesterol may be at risk of developing NASH.

COVID-19 update — we remain open.

For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.

COVID-19 SMART steps we are taking to ensure safety include:

  • Greatly increased availability of video office visits
  • Ensuring social distancing measures are taken in all waiting areas
  • Continuing the practice of cleaning and disinfecting exams rooms thoroughly between every patient visit
  • Appropriate personal protective equipment (PPE) for all staff members at our health clinics

Everything you need to know

As one of the largest and most recognised clinical trial organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself. A clinical trial offers an opportunity to help researchers find better treatments for others in the future.

If you have the following risk factors, you may be eligible to participate in a clinical trial:

  • Type 2 diabetes
  • Obesity
  • High blood pressure OR high cholesterol

It is a scan similar to an ultrasound used during pregnancy which will measure how elastic (or how stiff) your liver is. A healthy liver should be soft and elastic, and if your liver is stiff this is a sign that some damage has occurred.

How is it done?

It is a painless procedure which involves a probe being passed over the top right area of your stomach.

Your Fibroscan will be carried out at an outpatient clinic appointment.

What are the benefits?

The results of the scan can help your doctor find out about the level of damage that affects your liver, and decide what treatment you might need.

It is helpful for measuring the degree of liver damage in people with:

  • Viral hepatitis B and C
  • Alcoholic liver disease
  • Non-alcoholic fatty liver disease
  • Hepatitis C and HIV co-infection
  • Haemochromatosis (iron overload disorder)
  • Other liver diseases
  • What are the risks?

There are no risks involved. It is painless and not invasive (meaning it’s not carried out inside your body and does not break the skin).